The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Histological and biological evolution of human premalignant breast disease.
Abstract
Most human invasive breast cancers (IBCs) appear to develop over long periods of time from certain pre-existing benign lesions. Of the many types of benign lesions in the human breast, only a few appear to have significant premalignant potential. The best characterized of these include atypical hyperplasias and in situ carcinomas and both categories are probably well on along the evolutionary pathway to IBC. Very little is known about earlier premalignant alterations. All types of premalignant breast lesions are relatively common but only a small proportion appear to progress to IBC. They are currently defined by their histological features and their prognosis is imprecisely estimated from indirect epidemiological evidence. Although lesions within specific categories look alike, they must possess underlying biological differences causing some to remain stable and others to progress. Recent studies suggest that they evolve by highly diverse genetic mechanisms and research into these altered pathways may identify specific early defects that can be targeted to prevent premalignant lesions from developing or becoming cancerous. It is far more rational to think that breast cancer can be prevented than cured once it has developed fully. This review discusses histological models of human premalignant breast disease that provide the framework for scientific investigations into the biological alterations behind them and examples of specific biological alterations that appear to be particularly important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829
Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk
Pike, M. C., Spicer, D. V., Dahmoush, L., & Press, M. F. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036102 · Cited by 1,010
Atypical hyperplastic lesions of the female breast. A long-term follow-up study
Page, D. L., Dupont, W. D., Rogers, L. W., & Rados, M. S. (1985) · Cancer · doi:10.1002/1097-0142(19850601)55:11<2698::aid-cncr2820551127>3.0.co;2-a · Cited by 961
Nuclear receptor coactivators and corepressors
Horwitz, K. B. (1996) · Molecular Endocrinology · doi:10.1210/me.10.10.1167 · Cited by 942
Neu-Protein Overexpression in Breast Cancer
van de Vijver, M. J., Peterse, J. L., Mooi, W. J., Wisman, P., Lomans, J., Dalesio, O., & Nusse, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811103191902 · Cited by 860
Fisher, E. R., Sass, R., Fisher, B., Wickerham, L., Paik, S. M., & COLLABORATING NSABP INVESTIGATORS (1986) · Cancer · doi:10.1002/1097-0142(19860115)57:2<197::aid-cncr2820570203>3.0.co;2-n · Cited by 812
(1975) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/55.2.231 · Cited by 750
Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture.
Henderson, B. E., Ross, R. K., & Bernstein, L. (1988) · PubMed · Cited by 700
Cited by
Gene expression profiles of human breast cancer progression
Ma, X.-J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931261100 · Cited by 887
Ductal Carcinoma in Situ of the Breast
Burstein, H. J., Polyak, K., Wong, J. S., Lester, S. C., & Kaelin, C. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031301 · Cited by 759
Breast cancer: origins and evolution
Polyak, K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33295 · Cited by 697
Gene expression profiling of the tumor microenvironment during breast cancer progression
Ma, X.-J., Dahiya, S., Richardson, E., Erlander, M., & Sgroi, D. C. (2009) · Breast Cancer Research · doi:10.1186/bcr2222 · Cited by 629
Regulation of In Situ to Invasive Breast Carcinoma Transition
Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D., Richardson, A., Violette, S., Nikolskaya, T., Nikolsky, Y., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.007 · Cited by 502
Metadata
- Authors
- Allred, D. C., Mohsin, S. K., & Fuqua, S. A.
- Venue
- Endocrine-related cancer
- Publisher
- Bioscientifica
- Published
- 2001-03
- Volume
- 8
- Issue
- 1
- Pages
- 47-61
- ISSN
- 1351-0088 (ISSN-L)
- OpenAlex
- W2110279965
- Cited by
- 416
- References
- 65
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Histological and biological evolution of human premalignant breast disease. https://app.cochat.ai/papers/10.1677/erc.0.0080047
- The paper
- Allred, D. C., Mohsin, S. K., & Fuqua, S. A. (2001). Histological and biological evolution of human premalignant breast disease. Endocrine-related cancer. https://doi.org/10.1677/erc.0.0080047
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
